National Drug Code (NDC) Database
-
NDC:
20076-1245
-
Nonproprietary Name:
Moxidectin
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
MOXIDECTIN
-
Start Marketing Date:
2015-01-05
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
LIVZON NEW NORTH RIVER PHARMACEUTICAL CO.,LTD.
-
NDC:
20076-0402
-
Nonproprietary Name:
Lovastatin
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
LOVASTATIN
-
Start Marketing Date:
2015-05-23
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Loba biotech GmbH
-
NDC:
62668-6900
-
Nonproprietary Name:
Naphazoline Hydrochloride
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
NAPHAZOLINE HYDROCHLORIDE
-
Start Marketing Date:
2009-08-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Lonza AG
-
NDC:
49187-5002
-
Nonproprietary Name:
tividenofusp alfa-eknm
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
30 mg/mL
-
Substance:
TIVIDENOFUSP ALFA
-
Start Marketing Date:
2026-03-24
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Lonza Bend Inc
-
NDC:
87222-010
-
Nonproprietary Name:
Selumetinib
-
Dosage Form:
GRANULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
2.69 g/100g
-
Substance:
SELUMETINIB SULFATE
-
Start Marketing Date:
2026-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Lonza Bend Inc.
-
NDC:
87222-002
-
Nonproprietary Name:
lonafarnib
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1 mg/500mg
-
Substance:
LONAFARNIB
-
Start Marketing Date:
2026-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Lonza Biologics Inc.
-
NDC:
67643-0018
-
Nonproprietary Name:
Obiltoxaximab
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
145 mg/mL
-
Substance:
OBILTOXAXIMAB
-
Start Marketing Date:
2016-03-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Lonza Biologics Porrino, S.L.
-
NDC:
42098-0006
-
Nonproprietary Name:
andexanet alfa
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
20 mg/mL
-
Substance:
ANDEXANET ALFA
-
Start Marketing Date:
2019-01-11
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Lonza Biologics Tuas Pte Ltd.
-
NDC:
69438-0012
-
Nonproprietary Name:
dornase alfa
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
8 mg/mL
-
Substance:
DORNASE ALFA
-
Start Marketing Date:
2023-02-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
42513-0020
-
Nonproprietary Name:
Afoxolaner
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
AFOXOLANER
-
Start Marketing Date:
2024-08-14
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.